Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 27 , ISSUE 7 ( July, 2023 ) > List of Articles

Original Article

Epidemiology and Outcomes of HIN1 Pneumonia in ICU

Vinya Golagana, Ashwin K Mani, Ebenezer Rabindra Rajan, Dedeepiya Devaprasad Vidyasagar

Keywords : H1N1 pandemic influenza, Pandemic, Reverse transcription polymerase chain reaction

Citation Information : Golagana V, Mani AK, Rajan ER, Vidyasagar DD. Epidemiology and Outcomes of HIN1 Pneumonia in ICU. Indian J Crit Care Med 2023; 27 (7):470-474.

DOI: 10.5005/jp-journals-10071-24493

License: CC BY-NC 4.0

Published Online: 30-06-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Introduction: Pandemic influenza H1N1/09 emerged for the first time in April 2009 and has spread widely across India since then. The number of cases have increased over time with the increasing need for respiratory support, causing significant morbidity and mortality. We evaluated the clinical course and outcomes of patients infected with Influenza A (H1N1) admitted to three multidisciplinary intensive care units (ICU) in Chennai. Materials and methods: We performed a combined retrospective and prospective observational study of all patients admitted with H1N1 pneumonia at three multidisciplinary ICUs in Chennai from October 1, 2018, to January 31, 2019. Data including demographics, risk factors, and clinical courses were recorded. Outcome data including mortality was tracked up to 28 days. Results: A total of 167 patients were admitted during the study period of which 154 were included in this analysis. The mean age of presentation was 58.2 ± 15.6 years and 59.1% of them were males. The mean acute physiology and chronic health evaluation (APACHE) IV and sequential organ failure assessment (SOFA) scores were 62.8 ± 23.2 and 5.8 ± 3.9 respectively. Oxygen delivery devices were required in 25.3% for a mean duration of 26.5 ± 5.7 hours. Non-invasive ventilation or high-flow nasal cannula (HFNC) was needed in 33.1% of patients for 59.9 ± 64.5 hours. The proportion of patients requiring mechanical ventilation was 41.6%. Rescue measures in the form of proning, use of inhaled nitric oxide (iNO), and extracorporeal membrane oxygenation (ECMO) were initiated for refractory hypoxemia in 26.6%, 14.1%, and 6.3% respectively. The mean duration of ventilator support was 8.5 ± 8 days. Tracheostomy was required in 20.3% of patients and 7.8% were ventilator dependent at 28 days. The mean ICU and Hospital length of stay were 8.3 ± 10.3 and 12.2 ± 14.1 days respectively and overall 28-day mortality was 20.1%. Conclusion: A significant proportion of H1N1 patients admitted to the ICU required high-level respiratory support including non-invasive ventilation (NIV), HFNC, or invasive ventilation. Deployment of rescue therapies was common and the overall mortality rate was similar to those reported from Western countries.

  1. Rewar S, Mirdha D, Rewar P. Treatment and Prevention of Pandemic H1N1 Influenza. Annals of Global Health. 2015;81(5):645–653. DOI: 10.1016/j.aogh.2015.08.014.
  2. Kulkarni SV, Narain JP, Gupta S, Dhariwal AC, Singh SK, Macintyre CR. Influenza A (H1N1) in India: Changing epidemiology and its implications. Natl Med J India. 2019;32(2):107–108. DOI: 10.4103/0970-258X.253355.
  3. Narain JP, Kumar R, Bhatia R. Pandemic (H1N1) 2009: Epidemiological, clinical and prevention aspects. Natl Med J India 2009;22(5):242–247. PMID: 20334046.
  4. Jacob JK, Jacob SK, Samuel S, Renjith PG, Mathew A. Incidence and outcome of H1N1 cases in a Tertiary Care Hospital in South India: A retrospective observational study. Int J Sci Stud 2016;4(7):39–43. DOI: 10.17354/ijss/2016/522.
  5. WHO Pandemic (H1N1) 2009. World Health Organisation.
  6. Sahanaa C, Mishra AK. Influenza A in Southern states of India from 2010 to 2018: A trend analysis. Int J Med Sci Public Health 2019;8(11):939–943. DOI: 10.5455/ijmsph.2019.051503008201.
  7. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009;302(17):1880–1887. DOI: 10.1001/jama.2009.1536.
  8. Dhawale S, Jayant S. Clinical profile, morbidity and mortality among swine flu (H1N1) infected patients: 2015 Gwalior, Madhya Pradesh pandemic, India. Int J Adv Med 2016;3(2):324–327. DOI: 10.18203/2349-3933.ijam20161084.
  9. Wiesen J, Joshi D, Guzman JA, Duuggal A. Critical illness associated with 2013-2014 influenza A (H1N1): Post-pandemic characteristics, presentation and outcomes. Indian J Crit Care Med 2015;19(11): 636–640. DOI: 10.4103/0972-5229.169328.
  10. Linderman SL, Chambers BS, Zost SJ, Parkhouse K, Li Y, Herrmann C, et al. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. Proc Natl Acad Sci USA 2014;111(44):15798–15803. DOI: 10.1073/pnas.1409171111.
  11. Gurjar M. Postpandemic H1N1 influenza infection in ICU: Are we any wiser now?. Indian J Crit Care Med 2015;19(11):633–635. DOI: 10.4103/0972-5229.169323.
  12. Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo GG, Koukounari A, Donnelly CA, et al. Risk factors for severeoutcomes following 2009 influenza a (H1N1) infection: A Global pooled analysis. PLoS Med 2011;8(7):e1001053. DOI: 10.1371/journal.pmed.1001053.
  13. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza. JAMA 2009;302(17):1896–1902. DOI: 10.1001/jama.2009.1583.
  14. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009;361(7):680–689. DOI: 10.1056/NEJMoa0904252.
  15. Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, et al. Populations at risk for severe or complicated influenza illness: Systematic review and meta-analysis. BMJ 2013;347:f5061. DOI: 10.1136/bmj.f5061.
  16. Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;361(20):1925–1934. DOI: 10.1056/NEJMoa0908481.
  17. McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007;45(12): 1568–1575. DOI: 10.1086/523584.
  18. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al. Critically Ill Patients With 2009 Influenza A (H1N1) Infection in Canada. JAMA 2009;302(17):1872–1879. DOI: 10.1001/jama.2009.1496.
  19. Christian MD, Hawryluck L, Wax RS, Cook T, Lazar NM, Herridge MS, et al. Development of a triage protocol for critical care during an influenza pandemic. CMAJ 2006;175(11):1377–1381. DOI: 10.1503/cmaj.060911.
  20. Sood MM, Rigatto C, Zarychanski R, Komenda P, Sood AR, Bueti J, et al. Acute kidney injury in critically ill patients infected with 2009 pandemic influenza A (H1N1): Report from a Canadian Province. Am J Kidney Dis 2010;55(5):848–855. DOI: 10.1053/j.ajkd.2010.01.011.
  21. Purwar S, Venkataraman R, Senthilkumar R, Ramakrishnan N, Abraham BK. Noninvasive ventilation: Are we overdoing it? Indian J Crit Care Med 2014;18(8):503–507. DOI: 10.4103/0972-5229.138147.
  22. Chawla R, Kansal S, Chauhan M, Jain A, Jibhkate BN. Predictors of mortality and length of stay in hospitalized cases of 2009 influenza A (H1N1): Experiences of a tertiary care center. Indian J Crit Care Med 2013;17(5):275–282. DOI: 10.4103/0972-5229.120318.
  23. Ferrer M, Esquinas A, Leon M, Gonzalez G, Alarcon A, Torres A. Noninvasive ventilation in severe hypoxemic respiratory failure: A randomized clinical trial. Am J Respir Crit Care Med 2003;168(12): 1438–1444. DOI: 10.1164/rccm.200301-072OC.
  24. Agarwal R, Reddy C, Aggarwal AN, Gupta D. Is there a role for non-invasive ventilation in acute respiratory distress syndrome? A meta-analysis. Respir Med 2006;100(12):2235–2238. DOI: 10.1016/j.rmed.2006.03.018.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.